Clearmind reports no serious adverse events in CMND-100 dose trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. USO
6. AMD
7. TSLA
8. ACN
9. COHR
10. META

Go back to Clearmind reports no serious adverse events in CMND-100 dose trial
(NASDAQ: CMND) Delayed: 0.79 --0 (-0%)
Previous Close $0.79    52 Week High $ 
Open $0.79    52 Week Low $ 
Day High $0.79    P/E N/A 
Day Low $0.79    EPS $ 
Volume 2,811